Pinto Daniel, Rodrigues Ana Paula, Nunes Baltazar
Family Medicine Unit, NOVA Medical School, Lisbon, Portugal.
Department of Epidemiology, Dr. Ricardo Jorge National Institute of Health, Lisbon, Portugal.
Rev Port Cardiol (Engl Ed). 2018 Aug;37(8):657-663. doi: 10.1016/j.repc.2017.10.016. Epub 2018 Jul 17.
Finding out which drugs are chosen to treat incident cases of hypertension may help in interpreting prevalent use of antihypertensive agents. We aimed to determine the proportion of patients who begin treatment with each antihypertensive drug class, which physicians initiate treatment and whether family physicians alter prescriptions initiated by others, and to compare the prescribing patterns of family physicians and other specialists.
In this cohort-nested cross-sectional study between 2014 and 2015 within the Portuguese Sentinel Practice Network, family physicians notified incident cases of hypertension, reporting treatment, who issued the initial prescription and whether treatments initiated by other physicians were changed.
A total of 681 incident cases were notified. The initial prescription was issued by the patient's family physician in 86.9% of cases (95% CI: 84.2-89.3%). The most frequently used agents were angiotensin-converting enzyme inhibitors (51.3% of patients, 95% CI: 47.5-55.0%), thiazide and thiazide-like diuretics (32.2%, 95% CI: 28.8-35.8%), and angiotensin receptor blockers (21.4%, 95% CI: 18.5-24.7%). Compared to other specialists, family physicians used less beta-blockers (20.4 vs. 5.9%, p<0.001) and loop diuretics (8.2 vs. 0.8%, p=0.003). Prescriptions initiated by other specialists were changed by family physicians in 11.6% of cases (95% CI: 6.0-19.6%).
Angiotensin-converting enzyme inhibitors were the most frequently prescribed antihypertensive class. Most diagnoses were made by the patient's own family physician. Prescriptions initiated by other specialists were usually continued by family physicians. Prescribing patterns were similar between family physicians and other specialists, except for lower use of beta-blockers and loop diuretics.
查明选用哪些药物治疗新发高血压病例可能有助于解释抗高血压药物的普遍使用情况。我们旨在确定开始使用各类抗高血压药物治疗的患者比例、启动治疗的医生以及家庭医生是否会更改其他医生开具的处方,并比较家庭医生和其他专科医生的处方模式。
在2014年至2015年葡萄牙哨点医疗实践网络内进行的这项队列嵌套横断面研究中,家庭医生报告新发高血压病例,包括治疗情况、开具初始处方的医生以及其他医生启动的治疗是否被更改。
共报告了681例新发病例。86.9%的病例(95%可信区间:84.2 - 89.3%)的初始处方由患者的家庭医生开具。最常用的药物是血管紧张素转换酶抑制剂(51.3%的患者,95%可信区间:47.5 - 55.0%)、噻嗪类和噻嗪样利尿剂(32.2%,95%可信区间:28.8 - 35.8%)以及血管紧张素受体阻滞剂(21.4%,95%可信区间:18.5 - 24.7%)。与其他专科医生相比,家庭医生使用β受体阻滞剂(20.4%对5.9%,p<0.001)和襻利尿剂(8.2%对0.8%,p = 0.003)的比例较低。其他专科医生启动的处方在11.6%的病例中被家庭医生更改(95%可信区间:6.0 - 19.6%)。
血管紧张素转换酶抑制剂是最常开具的抗高血压药物类别。大多数诊断由患者自己的家庭医生做出。其他专科医生启动的处方通常由家庭医生继续使用。除了β受体阻滞剂和襻利尿剂的使用比例较低外,家庭医生和其他专科医生的处方模式相似。